Apologies for the delay in the October updates as I was busy trying out new visual things with my social media account which you can refer to here and here if you are interested. Do "follow" my social media account as there will be more frequent updates I will do to the account in the next few weeks, including some of the corporate updates and activities which I closely follow.

October has been a splendid month as the market went back into a volatile mode (particularly tech stocks) which means I get to play my trade position a couple times successfully during the month, earning myself a few good bucks which I used to add to my longer-term position.

First, I sold into one of my core position for Wilmar after it has confirmed the announcement of the listing of its subsidiary YKA. The market movement for Wilmar's share price has been unduly uncommonly seen in recent weeks, as it goes into huge market slides (not once but twice) despite YKA performing so well in its debut. The share price has been ranging between $4.25 to $4.75, with $4.40 seems like a stabilizer for a base position, so I took this opportunity to exit my position first with most of the "upside news" on the listing having been baked in. The next focus will probably turn into earnings season which I expect Wilmar to do relatively well.

I used this opportunity to also trade a couple of tech stocks during the recent correction, which I managed to buy and sell into a few tech positions such as Apple (bought more, then divested all), JD (bought more then divested all), and Crowdstrike. All three positions returned me a good > 25% returns within a space of a month, with the exception of JD, which gained around 48% across a span of 3 months.

I used the proceed from the funds to add to a new position for Bank of America, which I find they had a really solid Q3 recent earnings recently but were beaten down unduly from the market. BOA has not only managed to earn a profit of $5b in the quarter, but they have also managed to reverse some of the earlier provisions they made due to Covid-19, signaling that the worst is likely to be over. We should start to see a gradual stronger improvement right across from Q4 onwards. From a liquidity point of view, the CEO has also stated that they have never been stronger before since the Financial Crisis and that bodes for a strong recovery play as we edge closer to the end of the year.

I also added into my existing position for a recovery play for Singapore stocks - mainly doubling my position in Comfortdelgro, Jardine, and Starhill. I believe the three are still very much undervalued based on the currently ongoing development which I think will yield the highest return once a new development on Covid vaccine and phase 3 is announced.

The rest of the position remains relatively unchanged.

Networth Updates

The portfolio continued its strong month upwards trajectory by ending at $242,897, up from the previous month of $230,660.

It is still on track to hit the stretch target of $250k from the start of the year.

Given that most of the recovery play has not taken effect yet, I'm cautiously confident that the portfolio can outperform even better in FY2021 when the market starts to rotate into recovery stocks.

With the election just weeks away, Nov will look to be an interesting month once again and one which I will follow the development very close to the tail.

Cheers and stay invested!